BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  CooperCompanies Announces First Quarter 2023 Results

  CooperCompanies announced financial results for its fiscal first quarter ended January 31, 2023.

  March 2, 2023

   · 

  16 min read
• Business

  Cybin and The Chopra Foundation to Participate in Featured Session at Upcoming 2023 South by Southwest® Conference

  Cybin and The Chopra Foundation to Participate in Featured Session at Upcoming 2023 South by Southwest ® Conference.

  March 2, 2023

   · 

  3 min read
• BioCapital

  MacroGenics to Participate in Upcoming March 2023 Investor Conferences

  MacroGenics, Inc. announced that the Company’s management will participate in the following investor conferences in March 2023:

  March 2, 2023

   · 

  1 min read
• BioMidwest

  Centene to Present at Barclays 2023 Global Healthcare Conference

  Centene Corporation announced it will present at the Barclays 2023 Global Healthcare Conference, to be held Tuesday, March 14-Thursday, March 16, 2023, in Miami Beach, Florida.

  March 2, 2023

   · 

  1 min read
• Business

  Oncternal Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2022 Financial Results

  Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it will report fourth quarter and full year 2022 financial results after the U.S. financial markets close on Thursday, March 9, 2023.

  March 2, 2023

   · 

  2 min read
• Business

  enVVeno Medical Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update

  enVVeno Medical Corporation, a company setting new standards of care for the treatment of venous disease, provided a corporate update and reported financial results for the fourth quarter and year-end of 2022.

  March 2, 2023

   · 

  7 min read
• BioMidwest

  Mirion Technologies Announces Pricing of Public Offering by Selling Stockholders - March 03, 2023

  Mirion Technologies, Inc. announced the pricing of an underwritten public offering of 9,786,153 shares of Mirion’s Class A common stock by certain selling stockholders at a price to the public of $8.75 per share.

  March 2, 2023

   · 

  3 min read
• Business

  Paragon 28 Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance

  Paragon 28, Inc., a leading medical device company exclusively focused on the foot and ankle orthopedic market, reported financial results for the quarter and year ended December 31, 2022.

  March 2, 2023

   · 

  14 min read
• Biotech Beach

  Cidara Therapeutics Announces Underwritten Public Offerings of Common Stock and Preferred Stock

  Cidara Therapeutics, Inc. announced concurrent but separate underwritten public offerings of its common stock and its Series X Convertible Preferred Stock.

  March 2, 2023

   · 

  3 min read
• BioMidwest

  Viemed Healthcare Announces 2022 Financial Results

  Viemed Healthcare, Inc., a national leader in respiratory care and technology-enabled home medical equipment services, reported its financial results for the three months and year ended December 31, 2022.

  March 2, 2023

   · 

  15 min read